chr4-82429581-T-G

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2

The NM_031372.4(HNRNPDL):​c.110A>C​(p.Gln37Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,383,816 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00062 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0011 ( 1 hom. )

Consequence

HNRNPDL
NM_031372.4 missense

Scores

3
1
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.966

Publications

0 publications found
Variant links:
Genes affected
HNRNPDL (HGNC:5037): (heterogeneous nuclear ribonucleoprotein D like) This gene belongs to the subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has two RRM domains that bind to RNAs. Three alternatively spliced transcript variants have been described for this gene. One of the variants is probably not translated because the transcript is a candidate for nonsense-mediated mRNA decay. The protein isoforms encoded by this gene are similar to its family member HNRPD. [provided by RefSeq, May 2011]
HNRNPDL Gene-Disease associations (from GenCC):
  • autosomal dominant limb-girdle muscular dystrophy type 1G
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • muscular dystrophy, limb-girdle, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.14141434).
BP6
Variant 4-82429581-T-G is Benign according to our data. Variant chr4-82429581-T-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 464378.
BS2
High AC in GnomAd4 at 93 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNRNPDLNM_031372.4 linkc.110A>C p.Gln37Pro missense_variant Exon 1 of 8 ENST00000295470.10 NP_112740.1 O14979-1A0A024RDB5
HNRNPDLNM_001207000.1 linkc.110A>C p.Gln37Pro missense_variant Exon 1 of 7 NP_001193929.1 O14979A0A087WUK2
HNRNPDLNR_003249.2 linkn.645A>C non_coding_transcript_exon_variant Exon 1 of 9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNRNPDLENST00000295470.10 linkc.110A>C p.Gln37Pro missense_variant Exon 1 of 8 1 NM_031372.4 ENSP00000295470.5 O14979-1

Frequencies

GnomAD3 genomes
AF:
0.000617
AC:
93
AN:
150670
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000343
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000197
Gnomad ASJ
AF:
0.000290
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00109
Gnomad OTH
AF:
0.000484
GnomAD2 exomes
AF:
0.000306
AC:
5
AN:
16354
AF XY:
0.000480
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000770
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00108
AC:
1336
AN:
1233046
Hom.:
1
Cov.:
32
AF XY:
0.00104
AC XY:
625
AN XY:
598706
show subpopulations
African (AFR)
AF:
0.000257
AC:
6
AN:
23382
American (AMR)
AF:
0.000280
AC:
3
AN:
10732
Ashkenazi Jewish (ASJ)
AF:
0.000178
AC:
3
AN:
16864
East Asian (EAS)
AF:
0.00
AC:
0
AN:
28358
South Asian (SAS)
AF:
0.000147
AC:
8
AN:
54568
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
39306
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3570
European-Non Finnish (NFE)
AF:
0.00127
AC:
1278
AN:
1005890
Other (OTH)
AF:
0.000754
AC:
38
AN:
50376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.423
Heterozygous variant carriers
0
78
157
235
314
392
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000617
AC:
93
AN:
150770
Hom.:
0
Cov.:
32
AF XY:
0.000421
AC XY:
31
AN XY:
73648
show subpopulations
African (AFR)
AF:
0.000342
AC:
14
AN:
40878
American (AMR)
AF:
0.000197
AC:
3
AN:
15232
Ashkenazi Jewish (ASJ)
AF:
0.000290
AC:
1
AN:
3454
East Asian (EAS)
AF:
0.00
AC:
0
AN:
4972
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4796
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10534
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
288
European-Non Finnish (NFE)
AF:
0.00109
AC:
74
AN:
67624
Other (OTH)
AF:
0.000478
AC:
1
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
5
10
16
21
26
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000857
Hom.:
0
ExAC
AF:
0.0000502
AC:
3

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Autosomal dominant limb-girdle muscular dystrophy type 1G Uncertain:1Benign:1
Jan 13, 2022
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 15, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Jul 19, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.110A>C (p.Q37P) alteration is located in exon 1 (coding exon 1) of the HNRNPDL gene. This alteration results from a A to C substitution at nucleotide position 110, causing the glutamine (Q) at amino acid position 37 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.060
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.27
CADD
Benign
22
DANN
Benign
0.97
DEOGEN2
Benign
0.018
T;T;T
Eigen
Benign
-0.53
Eigen_PC
Benign
-0.39
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Benign
0.74
.;T;T
M_CAP
Pathogenic
0.75
D
MetaRNN
Benign
0.14
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N;N;.
PhyloP100
0.97
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-0.060
N;.;.
REVEL
Benign
0.19
Sift
Pathogenic
0.0
D;.;.
Polyphen
0.0040
B;B;.
Vest4
0.39
MVP
0.70
MPC
0.93
ClinPred
0.36
T
GERP RS
1.7
PromoterAI
0.020
Neutral
Varity_R
0.34
gMVP
0.21
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs911762606; hg19: chr4-83350734; API